Health Care Sector Update for 09/22/2016: ATRS, IONS

Comment

Shutterstock photo

Top Health-care stocks:

JNJ: +0.5%

PFE: +0.4%

ABT: flat

MRK: flat

AMGN: +0.4%

Health-care shares were mainly higher in pre-market trade on Thursday.

In health-care stocks news, Antares Pharma ( ATRS ) said Thursday it has completed a supplemental safety study for its QuickShot testosterone, completing the clinical work necessary to begin the new drug application submission process.

Shares in the company were unchanged at $1.61 pre-bell. The stock has traded between $0.67 and $1.89 over the past 52 weeks.

And Ionis Pharmaceuticals ( IONS ) said that clinical results of two randomized, controlled studies showed that its IONIS-APO (a) and IONIS-APO(a)-L reduced lipoprotein(a) by up to 99%. Shares in the company were 2.2% higher at $36.15 pre-bell.

The stock has traded between $19.59 and $62.68 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.



This article appears in: Investing , US Markets
Referenced Symbols: ATRS , IONS


More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com